Peter Johannes Holst (Peter Holst)

Scopus Author ID Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Venues

International journal of molecular sciences

Cancer immunology research

Expert review of vaccines

Science translational medicine

University of Copenhagen

University of Copenhagen (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Copenhagen Aug 15 2011

Denmark

Assocate Professor, head of Laboratory for Experimental Vaccinology :: Department of Immunology and Microbiology

Education History

University of Copenhagen Jan 17 2009

Denmark

PHD

Publications

Ditte Rahbaek Boilesen, Patrick Neckermann, Torsten Willert, Mikkel Dons Müller, Silke Schrödel, Cordula Pertl, Christian Thirion, Benedikt Asbach, Ralf Wagner, Peter Johannes Holst
Efficacy and Synergy with Cisplatin of an Adenovirus Vectored Therapeutic E1E2E6E7 Vaccine against HPV Genome-Positive C3 Cancers in Mice. Cancer immunology research 11 (2) (2023)
Isabella Skandorff, Emeline Ragonnaud, Jasmin Gille, Anne-Marie Andersson, Silke Schrödel, Lara Duvnjak, Louise Turner, Christian Thirion, Ralf Wagner, Peter Johannes Holst
Human Ad19a/64 HERV-W Vaccines Uncover Immunosuppression Domain-Dependent T-Cell Response Differences in Inbred Mice. International journal of molecular sciences 24 (12) (2023)
Isabella Skandorff, Emeline Ragonnaud, Jasmin Gille, Anne-Marie Andersson, Silke Schrödel, Lara Duvnjak, Louise Turner, Christian Thirion, Ralf Wagner, Peter Johannes Holst
Human Ad19a/64 HERV-W Vaccines Uncover Immunosuppression Domain-Dependent T-Cell Response Differences in Inbred Mice. International journal of molecular sciences 24 (12) (2023)
Isabella Skandorff, Emeline Ragonnaud, Jasmin Gille, Anne-Marie Andersson, Silke Schrödel, Lara Duvnjak, Louise Turner, Christian Thirion, Ralf Wagner, Peter Johannes Holst
Human Ad19a/64 HERV-W Vaccines Uncover Immunosuppression Domain-Dependent T-Cell Response Differences in Inbred Mice. International journal of molecular sciences 24 (12) (2023)
Ditte Rahbaek Boilesen, Patrick Neckermann, Torsten Willert, Mikkel Dons Müller, Silke Schrödel, Cordula Pertl, Christian Thirion, Benedikt Asbach, Ralf Wagner, Peter Johannes Holst
Efficacy and Synergy with Cisplatin of an Adenovirus Vectored Therapeutic E1E2E6E7 Vaccine against HPV Genome-Positive C3 Cancers in Mice. Cancer immunology research 11 (2) (2023)
Ditte Rahbaek Boilesen, Patrick Neckermann, Torsten Willert, Mikkel Dons Müller, Silke Schrödel, Cordula Pertl, Christian Thirion, Benedikt Asbach, Ralf Wagner, Peter Johannes Holst
Efficacy and synergy with cisplatin of an adenovirus vectored therapeutic E1E2E6E7 vaccine against HPV genome positive C3 cancers in mice. Cancer immunology research (2022)
Line Barington, Liv von Voss Christensen, Kristian Kåber Pedersen, Kristine Niss Arfelt, Martin Roumain, Kristian Høj Reveles Jensen, Viktoria Madeline Skovgaard Kjær, Viktorija Daugvilaite, John F Kearney, Jan Pravsgaard Christensen, Gertrud Malene Hjortø, Giulio G Muccioli, Peter Johannes Holst, Mette Marie Rosenkilde
GPR183 Is Dispensable for B1 Cell Accumulation and Function, but Affects B2 Cell Abundance, in the Omentum and Peritoneal Cavity. Cells 11 (3) (2022)
Ilaria Esposito, Paola Cicconi, Anna Morena D'Alise, Anthony Brown, Marialuisa Esposito, Leo Swadling, Peter Johannes Holst, Maria Rosaria Bassi, Mariano Stornaiuolo, Federica Mori, Ventzislav Vassilev, Wenqin Li, Timothy Donnison, Chiara Gentile, Bethany Turner, Annette von Delft, Mariarosaria Del Sorbo, Federica Barra, Alessandra Maria Contino, Adele Abbate, Allan Randrup Thomsen, Jan Pravsgaard Christensen, Armin Lahm, Fabiana Grazioli, Virginia Ammendola, Loredana Siani, Stefano Colloca, Paul Klenerman, Alfredo Nicosia, Lucy Dorrell, Antonella Folgori, Stefania Capone, Eleanor Barnes, null null
MHC class II invariant chain-adjuvanted viral vectored vaccines enhances T cell responses in humans. Science translational medicine 12 (548) (2021)
Lasse Neukirch, Cyrielle Fougeroux, Anne-Marie Carola Andersson, Peter Johannes Holst
The potential of adenoviral vaccine vectors with altered antigen presentation capabilities. Expert review of vaccines 19 (1) (2020)
Amaia Vergara Bermejo, Emeline Ragonnaud, Joana Daradoumis, Peter Johannes Holst
Cancer Associated Endogenous Retroviruses: Ideal Immune Targets for Adenovirus-Based Immunotherapy. International journal of molecular sciences 21 (14) (2020)

Peter Johannes Holst.css-eqlu8i{font-size:small;padding-left:4px;} (Peter Holst)

Publication Activity (10 Years)

Top Topics

Top Venues

Peter Johannes Holst (Peter Holst)